BOSTON SCIENTIFIC CORP Quarterly Unrecognized Tax Benefits in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Boston Scientific Corp quarterly Unrecognized Tax Benefits history and growth rate from Q2 2010 to Q3 2024.
  • Boston Scientific Corp Unrecognized Tax Benefits for the quarter ending September 30, 2024 was $493M, a 3.79% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $493M +$18M +3.79% Sep 30, 2024 10-Q 2024-11-01
Q2 2024 $478M +$7M +1.49% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $465M -$36M -7.19% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $467M -$25M -5.08% Dec 31, 2023 10-Q 2024-11-01
Q3 2023 $475M +$56M +13.4% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $471M +$60M +14.6% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $501M +$239M +91.2% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $492M +$237M +92.9% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $419M +$142M +51.3% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $411M +$131M +46.8% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $262M -$12M -4.38% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $255M -$6M -2.3% Dec 31, 2021 10-K 2024-02-20
Q3 2021 $277M -$2M -0.72% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $280M -$103M -26.9% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $274M -$175M -39% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $261M -$194M -42.6% Dec 31, 2020 10-K 2024-02-20
Q3 2020 $279M -$126M -31.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $383M -$30M -7.26% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $449M Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $455M +$28M +6.56% Dec 31, 2019 10-K 2023-02-23
Q3 2019 $405M -$106M -20.7% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $413M -$93M -18.4% Jun 30, 2019 10-Q 2019-07-30
Q4 2018 $427M -$811M -65.5% Dec 31, 2018 10-K 2022-02-23
Q3 2018 $511M -$617M -54.7% Sep 30, 2018 10-Q 2018-10-29
Q2 2018 $506M -$610M -54.7% Jun 30, 2018 10-Q 2018-07-31
Q1 2018 $1.24B +$134M +12.1% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 $1.24B +$143M +13.1% Dec 31, 2017 10-K 2021-02-23
Q3 2017 $1.13B +$62M +5.82% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 $1.12B +$58M +5.48% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $1.11B +$50M +4.74% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $1.1B +$39M +3.69% Dec 31, 2016 10-K 2020-02-25
Q3 2016 $1.07B -$20M -1.84% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 $1.06B -$10M -0.94% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 $1.06B $0 0% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $1.06B +$9M +0.86% Dec 31, 2015 10-K 2019-02-19
Q3 2015 $1.09B +$43M +4.12% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $1.07B +$29M +2.79% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $1.06B +$22M +2.13% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $1.05B -$55M -4.99% Dec 31, 2014 10-K 2018-02-20
Q3 2014 $1.04B -$37M -3.43% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $1.04B -$21M -1.98% Jun 30, 2014 10-Q 2014-08-06
Q1 2014 $1.03B -$15M -1.43% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $1.1B +$14M +1.29% Dec 31, 2013 10-K 2017-02-23
Q3 2013 $1.08B +$90M +9.09% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $1.06B +$90M +9.28% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $1.05B +$89M +9.27% Mar 31, 2013 10-Q/A 2013-05-07
Q4 2012 $1.09B +$66M +6.46% Dec 31, 2012 10-K 2016-02-24
Q3 2012 $990M +$55M +5.88% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $970M -$18M -1.82% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $960M -$26M -2.64% Mar 31, 2012 10-Q 2012-05-03
Q4 2011 $1.02B +$57M +5.91% Dec 31, 2011 10-K 2015-02-25
Q3 2011 $935M -$87M -8.51% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $988M -$41M -3.98% Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $986M Mar 31, 2011 10-Q 2011-05-05
Q4 2010 $965M Dec 31, 2010 10-K 2014-02-26
Q3 2010 $1.02B Sep 30, 2010 10-Q 2010-11-05
Q2 2010 $1.03B Jun 30, 2010 10-Q 2010-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.